C07K 14/755
Factors viii
Official title: Factors VIII {, e.g. factor VIII C (AHF), factor VIII Ag (VWF)}
C07K14/755 (Factors viii) appears on 867 US grants and 947 published applications in this corpus.
Search patents in C07K- Granted patents
- 867
- Published applications
- 947
- Assignees
- 432
- Inventors
- 1,668
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 3 | 0 |
| 1978 | 7 | 0 |
| 1979 | 4 | 0 |
| 1980 | 5 | 0 |
| 1981 | 8 | 0 |
| 1982 | 5 | 0 |
| 1983 | 7 | 0 |
| 1984 | 11 | 0 |
| 1985 | 8 | 0 |
| 1986 | 7 | 0 |
| 1987 | 11 | 0 |
| 1988 | 9 | 0 |
| 1989 | 14 | 0 |
| 1990 | 6 | 0 |
| 1991 | 10 | 0 |
| 1992 | 11 | 0 |
| 1993 | 13 | 0 |
| 1994 | 13 | 0 |
| 1995 | 14 | 0 |
| 1996 | 14 | 0 |
| 1997 | 31 | 0 |
| 1998 | 42 | 0 |
| 1999 | 34 | 0 |
| 2000 | 19 | 0 |
| 2001 | 22 | 4 |
| 2002 | 15 | 30 |
| 2003 | 12 | 40 |
| 2004 | 15 | 31 |
| 2005 | 14 | 27 |
| 2006 | 15 | 18 |
| 2007 | 12 | 20 |
| 2008 | 10 | 21 |
| 2009 | 15 | 30 |
| 2010 | 18 | 34 |
| 2011 | 25 | 27 |
| 2012 | 17 | 34 |
| 2013 | 18 | 47 |
| 2014 | 28 | 36 |
| 2015 | 26 | 52 |
| 2016 | 38 | 60 |
| 2017 | 23 | 51 |
| 2018 | 25 | 40 |
| 2019 | 32 | 58 |
| 2020 | 39 | 49 |
| 2021 | 35 | 45 |
| 2022 | 26 | 54 |
| 2023 | 24 | 35 |
| 2024 | 18 | 35 |
| 2025 | 23 | 36 |
| 2026 | 14 | 33 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Regulation of von Willebrand factor (VWF)18 Aug 2026US 12,709,754 B2Band Therapeutics, LLC
- Methods and compositions for treating cancer with von Willebrand factor peptide linked to immunotherapeutic antibodies11 Aug 2026US 12,706,227 B2The University of Chicago
- Optimized factor VIII gene14 Jul 2026US 12,679,882 B2Bioverativ Therapeutics Inc.
- Heterodimeric human IgG1 polypeptides with isoelectric point modifications23 Jun 2026US 12,662,553 B2Xencor, Inc.
- Post-natal transplantation of factor VIII-expressing cells for treatment of hemophilia9 Jun 2026US 12,648,967 B2Children's Healthcare of Atlanta, Inc.
- Fviii fusion protein conjugate having extended half-life and use thereof17 Sep 2026US 2026/0274923 A1Jiangsu Gensciences Inc.
- Lentiviral System17 Sep 2026US 2026/0275376 A1Expression Therapeutics LLC
- Post-Natal Transplantation Of Factor VIII-Expressing Cells For Treatment of Hemophilia27 Aug 2026US 2026/0248857 A1Children's Healthcare of Atlanta, Inc.
- Purification of chimeric fviii molecules27 Aug 2026US 2026/0250315 A1Bioverativ Therapeutics Inc.
- Compositions and methods for modulating factor viii function20 Aug 2026US 2026/0242823 A1
Most cited
By later US patents
- Positive-negative selection methods and vectors410US 5,464,764 AUniversity of Utah Research Foundation · 1995
- Cells and non-human organisms containing predetermined genomic modifications and positive-negative selection methods and vectors for making same308US 5,487,992 AUniversity of Utah Research Foundation · 1996
- Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor288US 7,282,199 B2The Trustees of the University of Pennsylvania · 2007
- Preparation of functional human factor VIII in mammalian cells using methotrexate based selection276US 4,965,199 AGenentech, Inc. · 1990
- Human factor VIII:C gene and recombinant methods for production226US 4,757,006 AGenetics Institute, Inc. · 1988